Biocompatibility of KLD-12 peptide hydrogel as a scaffold in tissue engineering of intervertebral discs in rabbits.
KLD-12 peptide with a sequence of AcN-KLDLKLDLKLDL-CNH(2) was synthesized and its biocompatibility was assessed in animals. Rabbit MSCs were cultured in the hydrogel for 2 weeks. Live cells were counted by using Calcein-AM/PI fluorescence staining. MTT was employed to assess the viability of MSCs cultured in KLD-12 peptide solution of 0.01%, 0.03%, and 0.05%. Hemolysis test, skin irritation test and implantation test were conducted to evaluate its biocompatibility with host tissues. Our results demonstrated that the MSCs in hydrogel grew well and maintained round shape. Cell survival rate was 92.15% (mean: 92.15%+/-1.17%) at the 7th day and there was no difference in survival rate between day 7 and day 14. Cell proliferation test showed that the A value of the KLD-12 solutions was not significantly different from that of control groups (complete culture media) (P>0.05) at the 24th and 48th h. The hemolysis rate of KLD-12 solution was 0.112%. Skin irritation test showed that the skin injected with KLD-12 solution remained normal and the score of skin irritation was 0. The histological examination with HE staining exhibited that the skin layers were clear and there was no infiltration with neutrophilic granulocytes and lymphocytes. It is concluded that KLD-12 peptide hydrogel had a good biocompatibility with host rabbit and MSCs, and KLD-12 peptide hydrogel can provide an appropriate microenvironment for MSCs.
Sun
Jianhua
J
Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. 007sunjianhua@sina.com
Zheng
Qixin
Q
Wu
Yongchao
Y
Liu
Yudong
Y
Guo
Xiaodong
X
Wu
Weigang
W
D000818:Animals; D001672:Biocompatible Materials; D001854:Bone Marrow Cells / Q000166:cytology / Q000502:physiology; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D020100:Hydrogels / Q000737:chemistry* / Q000494:pharmacology; D055959:Intervertebral Disc Degeneration / Q000473:pathology / Q000628:therapy*; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000502:physiology; D010455:Peptides / Q000737:chemistry*; D011817:Rabbits; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds
D001672:Biocompatible Materials; D020100:Hydrogels; D010455:Peptides
Biochem Soc Trans. 2002 Nov;30(Pt 6):874-8
12440936
Stem Cells. 2005 Mar;23(3):403-11
15749935
Spine (Phila Pa 1976). 1998 Apr 1;23(7):751-7
9563104
ANZ J Surg. 2004 Jan-Feb;74(1-2):46-54
14725706
Clin Orthop Relat Res. 2003 Jun;(411):305-14
12782889
J Huazhong Univ Sci Technolog Med Sci. 2009 Aug;29(4):512-6
19662373
J Neurosurg Spine. 2005 Apr;2(4):457-65
15871486
Spine (Phila Pa 1976). 2003 Mar 1;28(5):446-54; discussion 453
12616155
Eur Spine J. 2006 Aug;15 Suppl 3:S406-13
16845553
Spine (Phila Pa 1976). 1998 Sep 1;23(17):1821-7; discussion 1828
9762737
Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:6401-6
18003487
Arthritis Res Ther. 2009;11(1):R20
19210770
Expert Opin Biol Ther. 2003 Dec;3(8):1209-14
14640946
Biotech Histochem. 2003 Apr;78(2):109-17
14533847
J Biomed Mater Res A. 2003 Feb 1;64(2):248-56
12522811
Am J Pathol. 2004 Mar;164(3):915-24
14982845
Spine J. 2008 Nov-Dec;8(6):888-96
18082460
Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9996-10001
12119393
Spine (Phila Pa 1976). 2004 Dec 1;29(23):2627-32
15564911
Spine (Phila Pa 1976). 2003 Mar 15;28(6):548-53
12642760
Med Biol Eng Comput. 2003 May;41(3):365-71
12803304
Spine (Phila Pa 1976). 1987 Mar;12(2):97-104
2954220
Spine (Phila Pa 1976). 1995 Jun 1;20(11):1307-14
7660243
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2005 Feb;22(1):95-8
15762125